Aehr Test Systems AEHR

Aehr Test Systems es un proveedor de sistemas de prueba para quemar y probar circuitos integrados lógicos, ópticos y de memoria, con aproximadamente 2,500 sistemas instalados en todo el mundo. Los productos de la empresa incluyen el sistema ABTS, utilizado en la producción y prueba de calificación de partes empaquetadas para dispositivos lógicos de menor y mayor potencia, así como para todos los tipos comunes de dispositivos de memoria; el sistema FOX-XP, es un sistema de prueba y quemado de obleas completas y matrices/dados singulados utilizado para la prueba de quemado y funcional de dispositivos complejos, como memorias de vanguardia, procesadores de señales digitales, entre otros; el WaferPak Contactor, que es una tarjeta de prueba de obleas completas capaz de probar obleas que permite a los fabricantes de circuitos integrados (CI) realizar pruebas y quemados de obleas completas en los sistemas FOX de Aehr Test, y el DiePak Carrier, que es una placa de prueba reutilizable diseñada a medida para el sistema FOX-XP que permite a los fabricantes de CI realizar pruebas/quemados de dados y módulos singulados.

• Zacks Investment Research 30 sept

  AEHR vs. CAMT: Which Semiconductor Equipment Stock Is the Better Bet?

  Aehr Test Systems and Camtek are both positioned to benefit from AI and advanced packaging demand in semiconductors, but with different growth profiles. AEHR is entering a sharper growth phase with expected fiscal 2027 revenues of $130-$150 million (160%-200% growth) backed by a record $100.6 million backlog in AI-related burn-in solutions. CAMT offers broader exposure to advanced packaging and inspection/metrology with a strong $600 million order pipeline. Despite both carrying a Zacks Rank #3 (Hold), AEHR appears more compelling due to higher earnings-growth potential, though it trades at a premium valuation (P/S of 19.81X vs. CAMT's 9.88X).

  

• Zacks Investment Research 21 sept

  AEHR at 18.59X Sales: Market Loves Its AI Story, But is Love Blind?

  Aehr Test Systems (AEHR) has surged 363% in 2026 driven by AI semiconductor testing demand, but now trades at 18.59X forward sales—over 3x its historical median. While the company has strong backlog ($100.6M) and positive analyst sentiment, the elevated valuation leaves minimal margin for error. Key risks include heavy customer concentration (70% from top 5 customers), execution challenges, and semiconductor spending cyclicality. The stock carries a Zacks Rank #3 (Hold) rating.

  

• Zacks Investment Research 14 sept

  Can AEHR's Diversification Strengthen Its Growth Outlook?

  Aehr Test Systems has dramatically diversified its revenue streams, with AI processors and silicon photonics now driving nearly 95% of fiscal 2026 revenues, compared to over 95% EV-related SiC exposure two years prior. The company secured a $22 million follow-on order for AI processor systems in August and maintains a $100.6 million backlog with a $130-$150 million fiscal 2027 revenue outlook, though it faces intense competition from larger rivals Teradyne and FormFactor in the semiconductor test equipment market.

  

• The Motley Fool 31 ago

  Aehr Test Systems Insider Sells $847,000 Worth of Stock

  Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 5,994 shares worth $847,000 at $141.34 per share. The sale represents only a 3% reduction in his direct holdings, with Rogers retaining 186,232 shares valued at $27.1 million. The transaction occurred after the stock surged 695% over the past 12 months, and analysts view this as routine profit-taking rather than a sign of concern about the company's future.

  

• The Motley Fool 11 ago

  An Aehr Test Systems Vice President Sells 1,000 Shares as the Stock Soars. Here's a Deeper Look at the Transaction.

  Alistair N. Sporck, Vice President of Aehr Test Systems, sold 1,000 shares on August 10, 2026, for $108,490 at $108.49 per share, following a 484% one-year stock surge. The sale represents only 3% of his total equity position, suggesting continued alignment with the company. The stock's rise was driven by strong fiscal Q4 earnings with revenue of $18.8 million and a return to profitability, along with forecasted 160-200% revenue growth for fiscal 2027.